Abnormal expression of TOX3 could strengthen oncogenesis and metastasis in HCC both in vitro and in vivo through the MAPK and EMT pathways, whereas proteasome degradation of TOX3 is potentially mediated by the E3 ligase TRIM56. The gene discussed is TRIM56; the disease is hepatocellular carcinoma.